work
post image

Unpicking complex pricing and access opportunities for market expansion

  The challenge: Our client required strategic support to achieve successful reimbursed launches in the European region, despite the cost constraints of Western European health systems. In order to achieve ...
post image

Optimising a linked planning tool to inform design of future clinical trials

  The challenge: Our client planned to launch a novel asthma treatment into a future market set to be significantly different to what it is today. With the introduction of various new products with increased ...
post image

Sustained patient access training modules

  The challenge: Developing and maintaining the skills to ensure patient access at all levels of the organisation is critical to commercial success. Our client recognised this and the need to support global, ...
post image

Maximising patient access through real world evidence generation

  The challenge: Our client’s second-in-class biologic was approaching re-review in many markets. With increasing scrutiny and demand from healthcare decision-makers, our client recognized the need for real ...
post image

Mapping access and funding routes

  The challenge: Our client had a range of novel biologics in the pipeline for a therapy area in which they had no previous experience. Adding to this, the therapy area presented a particularly challenging PRA ...
post image

HTA landscape assessment for biologics

  The challenge: Following several other successful topical, systemic and biologic agents into a crowded market, our client found themselves facing a considerable challenge launching their first ever biologic. ...
post image

Understanding the impact of biosimilars

The challenge: The loss of exclusivity for biologic products and the launch of biosimilar competitors is expected to alter the existing landscape in several therapy areas. We have worked with clients to explore the ...
post image

Understanding how value translates between different decision makers

The challenge: Our client wanted to understand how the drivers of value for patients and prescribers might translate into payer value drivers.  They wanted to determine whether showing that patients and prescribers see ...
post image

Optimising a value demonstration tool
to stay ahead of a rising competitor

The challenge: Our client’s brand was facing market share erosion from the key competitor; the competitor was a slightly lower price and some stakeholders perceived little differentiation. To address this, the team ...
post image

Assessing the commercial opportunity for an innovative wound care device

The challenge: Our client wanted to understand the potential commercial opportunity for their device within the community setting, together with an assessment of the hurdles to achieving reimbursement (and the investment ...
post image

Understanding payer perceptions of adherence

The challenge: Our client believed that adherence programs could help drive competitive advantage for their brands. They wanted to understand: Whether payers recognise adherence as a driver of costs and poor ...
post image

Mapping supply chain and funding flows in a neurological disease area

   The challenge: Our client needed to understand funding and discounting practice in order to optimise their pricing strategy versus competitor brands in 5 markets (their product is specialist initiated but ...